ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 148 filers reported holding ACCELERON PHARMA INC in Q4 2016. The put-call ratio across all filers is 3.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,471,000 | +29320.0% | 8,553 | +17718.8% | 0.11% | +10700.0% |
Q3 2020 | $5,000 | -98.4% | 48 | -99.2% | 0.00% | -96.9% |
Q4 2019 | $319,000 | +314.3% | 6,017 | +205.3% | 0.03% | +300.0% |
Q3 2019 | $77,000 | +71.1% | 1,971 | +79.2% | 0.01% | +60.0% |
Q2 2019 | $45,000 | +95.7% | 1,100 | +165.7% | 0.01% | +150.0% |
Q3 2018 | $23,000 | -23.3% | 414 | -33.4% | 0.00% | 0.0% |
Q2 2018 | $30,000 | -72.2% | 622 | -78.7% | 0.00% | -80.0% |
Q3 2017 | $108,000 | +535.3% | 2,917 | +416.3% | 0.01% | +400.0% |
Q2 2017 | $17,000 | -61.4% | 565 | -54.5% | 0.00% | -60.0% |
Q3 2016 | $44,000 | -12.0% | 1,242 | -16.4% | 0.01% | 0.0% |
Q2 2016 | $50,000 | -35.1% | 1,485 | -49.3% | 0.01% | -58.3% |
Q1 2016 | $77,000 | -57.7% | 2,930 | -60.1% | 0.01% | -62.5% |
Q3 2015 | $182,000 | +127.5% | 7,345 | +187.1% | 0.03% | +128.6% |
Q2 2015 | $80,000 | +105.1% | 2,558 | +149.8% | 0.01% | +7.7% |
Q4 2014 | $39,000 | +18.2% | 1,024 | +2.4% | 0.01% | +160.0% |
Q2 2014 | $33,000 | – | 1,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |